Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of Circulating Tumor Cells

NCT04912882 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04912882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04912882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of Circulating Tumor Cells
Lead sponsor
Fudan University
Phase
Observational
Overall status
Unknown status
Start date
June 15, 2021
Completion date
December 1, 2025
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

circulating tumor cell, colorectal cancer